| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A non-interventional study of biosimilar granulocyte colony-stimulating factor as prophylaxis for chemotherapy-induced neutropenia in a community oncology centre
|
Verpoort, Karl
|
|
2012
|
|
6 |
p. 289-293
|
artikel
|
| 2 |
Antiangiogenesis therapy in the treatment of metastatic colorectal cancer
|
Grothey, Axel
|
|
2012
|
|
6 |
p. 301-319
|
artikel
|
| 3 |
Checkpoint inhibitors in lung cancer: latest developments and clinical potential
|
Schvartsman, Gustavo
|
|
2016
|
|
6 |
p. 460-473
|
artikel
|
| 4 |
Choosing chemotherapy in patients with advanced urothelial cell cancer who are unfit to receive cisplatin-based chemotherapy
|
de Vos, F.Y.F.L.
|
|
2010
|
|
6 |
p. 381-388
|
artikel
|
| 5 |
Circulating tumour cells: their utility in cancer management and predicting outcomes
|
Krebs, Matthew G.
|
|
2010
|
|
6 |
p. 351-365
|
artikel
|
| 6 |
Corrigendum
|
|
|
2012
|
|
6 |
p. 347-348
|
artikel
|
| 7 |
Deciding site of biopsy at metastatic relapse
|
Venniyoor, Ajit
|
|
2014
|
|
6 |
p. 305-305
|
artikel
|
| 8 |
Deciding site of biopsy at metastatic relapse: reply
|
Janku, Filip
|
|
2014
|
|
6 |
p. 306-306
|
artikel
|
| 9 |
Early palliative care in cancer treatment: rationale, evidence and clinical implications
|
Howie, Lynn
|
|
2013
|
|
6 |
p. 318-323
|
artikel
|
| 10 |
Fertility preservation in males with cancer: 16-year monocentric experience of sperm banking and post-thaw reproductive outcomes
|
Depalo, Raffaella
|
|
2016
|
|
6 |
p. 412-420
|
artikel
|
| 11 |
Harnessing gemcitabine metabolism: a step towards personalized medicine for pancreatic cancer
|
Saif, Muhammad Wasif
|
|
2012
|
|
6 |
p. 341-346
|
artikel
|
| 12 |
Human epidermal growth factor receptor 2 positive (HER2+) metastatic breast cancer: how the latest results are improving therapeutic options
|
Jiang, Hanfang
|
|
2015
|
|
6 |
p. 321-339
|
artikel
|
| 13 |
Intermittent dosing with vemurafenib in BRAF V600E-mutant melanoma: review of a case series
|
Dooley, Andrew J.
|
|
2014
|
|
6 |
p. 262-266
|
artikel
|
| 14 |
Latest therapeutic advances from the ASCO 2010 Annual Meeting
|
Coombes, R. Charles
|
|
2010
|
|
6 |
p. 347-350
|
artikel
|
| 15 |
Letter to the Editor Re: Ahn DH, Krishna K, Blazer M, et al. “A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis.” Ther Adv Med Oncol https://doi.org/10.1177/1758834016676011
|
Von Hoff, Daniel D
|
|
2017
|
|
6 |
p. 441-443
|
artikel
|
| 16 |
Long-term survival in a patient with glioblastoma on antipsychotic therapy for schizophrenia: a case report and literature review
|
Faraz, Shahdabul
|
|
2016
|
|
6 |
p. 421-428
|
artikel
|
| 17 |
Multimodality treatment of brain metastases from renal cell carcinoma in the era of targeted therapy
|
Bassanelli, Maria
|
|
2016
|
|
6 |
p. 450-459
|
artikel
|
| 18 |
Neoadjuvant chemotherapy in advanced ovarian cancer: latest results and place in therapy
|
Sato, Seiya
|
|
2014
|
|
6 |
p. 293-304
|
artikel
|
| 19 |
Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications
|
Pasquali, Sandro
|
|
2017
|
|
6 |
p. 415-429
|
artikel
|
| 20 |
Older patients with breast cancer: is there bias in the treatment they receive?
|
Markopoulos, Christos
|
|
2012
|
|
6 |
p. 321-327
|
artikel
|
| 21 |
Optimal management of hormone receptor positive metastatic breast cancer in 2016
|
Reinert, Tomas
|
|
2015
|
|
6 |
p. 304-320
|
artikel
|
| 22 |
Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapy
|
Ricciuti, Biagio
|
|
2017
|
|
6 |
p. 387-404
|
artikel
|
| 23 |
Overcoming docetaxel resistance in prostate cancer: a perspective review
|
Hwang, Clara
|
|
2012
|
|
6 |
p. 329-340
|
artikel
|
| 24 |
Pembrolizumab in cervical cancer: latest evidence and clinical usefulness
|
Borcoman, Edith
|
|
2017
|
|
6 |
p. 431-439
|
artikel
|
| 25 |
Preventing bowel cancer: an insight for clinicians
|
Hart, Andrew R.
|
|
2011
|
|
6 |
p. 269-277
|
artikel
|
| 26 |
Resistance to therapy in estrogen receptor positive and human epidermal growth factor 2 positive breast cancers: progress with latest therapeutic strategies
|
Lousberg, Laurence
|
|
2016
|
|
6 |
p. 429-449
|
artikel
|
| 27 |
Response to Drs Von Hoff and Renschler
|
Ahn, Daniel H.
|
|
2017
|
|
6 |
p. 445-446
|
artikel
|
| 28 |
Review of the use of pretest probability for molecular testing in non-small cell lung cancer and overview of new mutations that may affect clinical practice
|
Martin, Petra
|
|
2017
|
|
6 |
p. 405-414
|
artikel
|
| 29 |
Targeting angiogenesis in advanced cervical cancer
|
Eskander, Ramez N.
|
|
2014
|
|
6 |
p. 280-292
|
artikel
|
| 30 |
Targeting angiogenesis in melanoma: prospects for the future
|
Corrie, P.G.
|
|
2010
|
|
6 |
p. 367-380
|
artikel
|
| 31 |
The potential for crizotinib in non-small cell lung cancer: a perspective review
|
Bang, Yung-Jue
|
|
2011
|
|
6 |
p. 279-291
|
artikel
|
| 32 |
The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy
|
Javle, M.
|
|
2011
|
|
6 |
p. 257-267
|
artikel
|
| 33 |
Therapeutic potential of TAS-102 in the treatment of gastrointestinal malignancies
|
Peters, Godefridus J.
|
|
2015
|
|
6 |
p. 340-356
|
artikel
|
| 34 |
The role of peri-operative treatment in resectable liver metastases of colorectal cancer
|
Stein, Alexander
|
|
2010
|
|
6 |
p. 389-398
|
artikel
|
| 35 |
Treatment strategies for radioactive iodine-refractory differentiated thyroid cancer
|
Worden, Francis
|
|
2014
|
|
6 |
p. 267-279
|
artikel
|
| 36 |
Unusual suspects: pulmonary opportunistic infections masquerading as tumor metastasis in a patient with adrenocorticotropic hormone-producing pancreatic neuroendocrine cancer
|
Chowdry, Rajasree P.
|
|
2012
|
|
6 |
p. 295-300
|
artikel
|
| 37 |
Vascular endothelial growth factor receptor tyrosine kinase inhibitors in metastatic renal cell cancer: latest results and clinical implications
|
Aslam, Shahzeena
|
|
2013
|
|
6 |
p. 324-333
|
artikel
|
| 38 |
Which patients with metastatic breast cancer benefit from subsequent lines of treatment? An update for clinicians
|
Palumbo, Raffaella
|
|
2013
|
|
6 |
p. 334-350
|
artikel
|
| 39 |
Zoledronic acid in breast cancer: latest findings and interpretations
|
Gnant, Michael
|
|
2011
|
|
6 |
p. 293-301
|
artikel
|
Tijdschrift beschrijving